Skip to main content
NanoRepro AG logo

NanoRepro AG — Investor Relations & Filings

Ticker · NN6 ISIN · DE0006577109 LEI · 3912008FCA63AGIMEV74 F Manufacturing
Open in API
Filings indexed 415 across all filing types
Latest filing 2012-07-25 Regulatory Filings
Country DE Germany
Listing F NN6

About NanoRepro AG

https://www.nanorepro.com/en/

NanoRepro AG is a company specializing in the development, manufacturing, and distribution of CE-marked rapid diagnostic tests (self-tests) and food supplements. The products are designed for both home and professional use. The company's portfolio covers various health areas, including family planning, preventive healthcare, disease detection, food intolerances, allergies, and infectious diseases. The primary goal is to provide accuracy in self-diagnostics for rapid disease detection and health monitoring.

Recent filings

Filing Released Lang Actions
NanoRepro AG: NanoRepro AG erweitert Produktpalette: Auftrage fur Alkohol-Test nach franzosischer NF-Norm
Regulatory Filings Classification · 100% confidence The document is a press release dated July 25, 2012, announcing a new product introduction (Alcohol Test) and strategic business decision (expanding into the French market based on new mandatory regulations). It details product standards, initial orders, and market potential. This type of announcement, focusing on a new product launch and strategic move rather than routine financial results (ER/IR) or mandatory regulatory filings (10-K/AR), fits best under a general corporate news or product announcement category. Since there is no specific code for 'Product Launch' or 'Strategic Update' that isn't covered by the existing list, and it is not a formal financial report, a proxy for general corporate news or a specific strategic announcement is needed. Given the content is about a new product and market entry, it is a significant corporate event announcement. It is not a standard Earnings Release (ER), Interim Report (IR), or a formal regulatory filing like 10-K. It is most closely aligned with a general corporate announcement that doesn't fit the highly specific categories. However, looking closely at the definitions, it describes a strategic business decision and product expansion. Since there isn't a perfect fit like 'Product Launch', and it is a news release about business operations, the most appropriate fallback among the provided options that captures a significant, non-financial-reporting corporate event is often 'Regulatory Filings' (RNS) if it were a mandatory filing, or if we interpret 'Corporate News' as a general announcement. Since the text is a 'News Details' release announcing a product expansion and market entry, and it is not a formal financial report, it is best classified as a general regulatory announcement or news release that doesn't fit the other specific financial/governance codes. RNS is the general regulatory announcement fallback. If we consider the content as a strategic business update, it still defaults to RNS as the best fit among the provided codes for non-standard corporate news.
2012-07-25 German
NanoRepro AG erweitert Absatzmarkte: Einstieg in Rumanien und Albanien gelungen
Regulatory Filings Classification · 95% confidence The document is a short news release dated July 13, 2012, titled "NanoRepro AG erweitert Absatzmärkte: Einstieg in Rumänien und Albanien gelungen" (NanoRepro AG expands sales markets: Entry into Romania and Albania successful). It discusses strategic expansion, securing a first large order from a new investor, and mentions an upcoming Annual General Meeting (AGM) on 28.08.2012 where a mandate for the supervisory board will be sought. The text is clearly an announcement of strategic business developments and financing activities (mentioning a recent capital increase). Since it announces strategic expansion and financing, it fits best under Capital/Financing Update (CAP) or potentially Regulatory Filings (RNS) if it were a general announcement. However, the core content relates to expansion funded by recent capital, making CAP a strong candidate. Given the context of a general news release about strategic moves and financing, and the short length (under 5,000 characters), it is not a comprehensive report (like 10-K or IR). It is a specific corporate action announcement. Since 'CAP' covers fundraising and capital structure changes, and this announcement follows a capital increase used for expansion, CAP is the most appropriate specific code. It is not an ER (Earnings Release) as it focuses on strategy/sales, not financial results highlights.
2012-07-13 German
Jahresabschluss zum Geschäftsjahr vom 01.01.2011 bis zum 31.12.2011
Audit Report / Information Classification · 98% confidence The document is a formal 'Jahresabschluss' (Annual Financial Statement) for NanoRepro AG for the fiscal year 2011. It contains a balance sheet (Bilanz), notes to the financial statements (Anhang), and details regarding the board and management. While it is not a full 10-K (which is a US-specific regulatory filing), it serves the exact function of an Annual Report in the German jurisdiction, providing comprehensive financial performance and activity for the year. Given the provided categories, '10-K' is the designated code for an Annual Report. FY 2011
2012-07-11 German
NanoRepro AG: NanoRepro AG fuhrt Kapitalerhohung erfolgreich durch
Share Issue/Capital Change Classification · 99% confidence The document is a corporate news release dated June 28, 2012, with the headline "NanoRepro AG führt Kapitalerhöhung erfolgreich durch" (NanoRepro AG successfully completes capital increase). The text explicitly details the increase of the share capital, the gross proceeds (EUR 595,660), the issuance price (EUR 2.90), and the strategic use of the funds, including securing a strategic investor. This content directly relates to fundraising, financing activities, and capital structure changes. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is short (4199 chars), but it is the primary announcement of the event, not just an announcement that a report is attached, making CAP more specific than RPA or RNS.
2012-06-28 German
NanoRepro AG: Groter Auftrag der Frmengeschichte, Vertriebs-Vertrag fur Kuwait garantiert ein Umsatzplus von 200 000 bis 300 000 Euro
Regulatory Filings Classification · 95% confidence The document is a short news release dated June 6, 2012, announcing a major sales contract and strategic alliance for sales in Kuwait and the Middle East, guaranteeing a revenue increase of 200,000 to 300,000 Euros. It details a new distribution agreement and lists the company's current product portfolio (self-diagnostics). The text ends with a standard footer indicating it is a 'Corporate News/Finanznachricht' distributed by DGAP. Since this is a specific announcement about a contract/revenue development rather than a full financial report (10-K, IR) or a general regulatory filing (RNS), it best fits the 'Capital/Financing Update' (CAP) or potentially 'Regulatory Filings' (RNS) if the contract itself is considered a material event disclosure. Given the focus on a significant contract guaranteeing revenue, it is a material business event disclosure. However, none of the definitions perfectly capture a 'Major Contract Announcement' outside of financing (CAP) or general news (RNS). Since it is a specific business development announcement that is not a standard financial report, earnings release, or management change, and it is not a proxy/dividend/insider trade notice, the most appropriate general category for material, non-standard corporate news that isn't a formal report is RNS (Regulatory Filings/General Announcement). If a more specific category existed for 'Material Contract Award', that would be chosen. Based on the provided definitions, RNS serves as the best fallback for significant, non-standard corporate news releases.
2012-06-06 German
NanoRepro AG: Medizinische Homepage fur turkischsprachige Mitburger
Regulatory Filings Classification · 95% confidence The document is a short news release dated May 22, 2012, from NanoRepro AG, announcing the launch of a new medical information and ordering platform specifically targeting Turkish-speaking citizens in Germany (www.evdetest.de). It discusses a strategic business decision (product introduction/expansion) and quotes the CEO regarding expansion strategy. It is not a full financial report (10-K, IR), an earnings release (ER), a management discussion (MDA), or a formal regulatory filing like a DIRS or MRQ. Since it announces a strategic business development and product launch, it fits best under a general corporate announcement category. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for general corporate news that doesn't fit the highly specific financial or governance categories, although 'Strategic Corporate Decision/Product Introduction' is mentioned in the keywords, which isn't a direct code. Since it's a standard news release about business operations, RNS is the best fit among the provided codes, as it is a general corporate news item distributed via DGAP.
2012-05-22 German

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.